Data from the Evoke trials suggests that GLP-1 drugs that treat type 2 diabetes do not have a significant effect on Alzheimer ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

A new study suggests that arginine, a common amino acid, may help reduce the brain plaques associated with Alzheimer’s ...

Dementia is the deterioration of brain functioning beyond that of normal ageing. There are multiple types, the most common being Alzheimer’s disease. Factors such as smoking, being overweight, heavy ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing cancer drugs. The research suggests that targeting multiple types of brain ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

According to the Alzheimer's Association, in the Treasure State, around 21 thousand people over the age of 65 are living with ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.